LT3490988T - Naujas junginys ir gavimo būdas - Google Patents

Naujas junginys ir gavimo būdas

Info

Publication number
LT3490988T
LT3490988T LTEP17748880.6T LT17748880T LT3490988T LT 3490988 T LT3490988 T LT 3490988T LT 17748880 T LT17748880 T LT 17748880T LT 3490988 T LT3490988 T LT 3490988T
Authority
LT
Lithuania
Prior art keywords
preparation
new compound
compound
new
Prior art date
Application number
LTEP17748880.6T
Other languages
English (en)
Lithuanian (lt)
Inventor
Peter Lionel Spargo
Original Assignee
Verona Pharma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verona Pharma Plc filed Critical Verona Pharma Plc
Publication of LT3490988T publication Critical patent/LT3490988T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
LTEP17748880.6T 2016-07-28 2017-07-27 Naujas junginys ir gavimo būdas LT3490988T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1613054.4A GB201613054D0 (en) 2016-07-28 2016-07-28 New compound and process
PCT/GB2017/052190 WO2018020249A1 (en) 2016-07-28 2017-07-27 New compound and process

Publications (1)

Publication Number Publication Date
LT3490988T true LT3490988T (lt) 2019-10-10

Family

ID=56936838

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP17748880.6T LT3490988T (lt) 2016-07-28 2017-07-27 Naujas junginys ir gavimo būdas

Country Status (19)

Country Link
US (1) US10710998B2 (https=)
EP (1) EP3490988B1 (https=)
JP (1) JP6985367B2 (https=)
KR (1) KR102396059B1 (https=)
CN (1) CN109641891B (https=)
CY (1) CY1122138T1 (https=)
DK (1) DK3490988T3 (https=)
ES (1) ES2751948T3 (https=)
GB (1) GB201613054D0 (https=)
HR (1) HRP20192109T1 (https=)
HU (1) HUE046509T2 (https=)
LT (1) LT3490988T (https=)
PL (1) PL3490988T3 (https=)
PT (1) PT3490988T (https=)
RS (1) RS59566B1 (https=)
SI (1) SI3490988T1 (https=)
SM (1) SMT201900582T1 (https=)
TW (1) TWI739871B (https=)
WO (1) WO2018020249A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3142701T3 (en) 2014-05-12 2018-08-13 Verona Pharma Plc New treatment
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound
PT4090654T (pt) * 2020-01-17 2025-10-07 Lupin Ltd Métodos, processos e intermediários para a preparação de compostos de cromano
CN116917287A (zh) 2021-04-29 2023-10-20 苏州盛迪亚生物医药有限公司 异喹啉酮类化合物及其用途
JP2024545189A (ja) * 2021-12-14 2024-12-05 シーツァン ハイスコ ファーマスーティカル カンパニー リミテッド 三環式縮合複素環系pde3/4二重阻害剤及びその用途
GB202202297D0 (en) 2022-02-21 2022-04-06 Verona Pharma Plc Formulation production process
EP4378942A1 (en) 2022-12-02 2024-06-05 Sandoz AG Crystal form of a pde3/4 inhibitor
WO2025003643A1 (en) 2023-06-26 2025-01-02 Verona Pharma Plc Particulate composition comprising ensifetrine
CN121620356A (zh) 2023-06-26 2026-03-06 维罗纳制药公司 包含恩塞芬汀的颗粒组合物
US20250073240A1 (en) 2023-09-06 2025-03-06 Verona Pharma Plc New treatment
US20250249007A1 (en) 2024-02-07 2025-08-07 Verona Pharma Plc Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease
WO2025168708A1 (en) 2024-02-07 2025-08-14 Verona Pharma Plc Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease
WO2025176871A1 (en) 2024-02-23 2025-08-28 Inke, S.A. Process for preparing pyrimido[6,1-a]isoquinoline-4-ones

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ185900A (en) 1976-12-10 1981-04-24 Hoechst Ag Pyrimido (6,1-a) isoquinolin-4-ones medicaments intermediate isoquinolines
FI64370C (fi) 1977-05-05 1983-11-10 Hoechst Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara pyimido-(6,1-a)isokinolin-2-imino-4-onderivat
DE2847693A1 (de) 1978-11-03 1980-05-22 Hoechst Ag Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
DE3135831A1 (de) 1981-09-10 1983-04-28 Hoechst Ag, 6230 Frankfurt 9,10-substituierte 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-pyrimido(6,1-a)isochinolin-4-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CA1237429A (en) 1983-05-05 1988-05-31 Frank Kienzle Pyrimidone derivatives
ES2208310T3 (es) 1999-03-31 2004-06-16 Vernalis Limited Derivados de pirimido(6,1-a) isoquinolin-4-ona.
PH12013500261A1 (en) 2010-08-09 2013-03-04 Verona Pharma Plc Crystalline form of pyrimidio[6,1-a]isoquinolin-4-one compound
EP2968313B1 (en) 2013-03-15 2018-01-31 Verona Pharma PLC Drug combination
DK3142701T3 (en) 2014-05-12 2018-08-13 Verona Pharma Plc New treatment
CN110051627A (zh) 2014-09-15 2019-07-26 维罗纳制药公司 包含rpl554的液体吸入制剂
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound

Also Published As

Publication number Publication date
SMT201900582T1 (it) 2019-11-13
CY1122138T1 (el) 2020-11-25
JP2019527228A (ja) 2019-09-26
TWI739871B (zh) 2021-09-21
SI3490988T1 (sl) 2019-11-29
KR20190034231A (ko) 2019-04-01
PL3490988T3 (pl) 2020-02-28
EP3490988A1 (en) 2019-06-05
US10710998B2 (en) 2020-07-14
HRP20192109T1 (hr) 2020-02-21
US20190330206A1 (en) 2019-10-31
HUE046509T2 (hu) 2020-03-30
JP6985367B2 (ja) 2021-12-22
DK3490988T3 (da) 2019-10-28
GB201613054D0 (en) 2016-09-14
KR102396059B1 (ko) 2022-05-10
WO2018020249A1 (en) 2018-02-01
RS59566B1 (sr) 2019-12-31
EP3490988B1 (en) 2019-08-28
PT3490988T (pt) 2019-10-28
CN109641891A (zh) 2019-04-16
ES2751948T3 (es) 2020-04-02
TW201806951A (zh) 2018-03-01
CN109641891B (zh) 2021-05-04

Similar Documents

Publication Publication Date Title
LT3490988T (lt) Naujas junginys ir gavimo būdas
LT3653221T (lt) Anti-pvrig antikūnai ir naudojimo būdai
IL257663B (en) Oral care compositions and methods of use
PL3507418T3 (pl) Sposoby biopochodnej derywatyzacji powierzchni celulozowych
EP4212536C0 (en) BENZOXAZEPINE OXAZOLIDINONE COMPOUNDS AND METHODS OF USE
PT3548033T (pt) Compostos e respectivos métodos de utilização
PL3325443T3 (pl) Sposób otrzymywania pridopidyny
IL252602B (en) Oral care compositions and methods of use
IL251988A0 (en) Glycan-interacting compounds and methods of use
PT3368534T (pt) Ditosilato de valbenazina e polimorfos do mesmo
LT3212189T (lt) Pakeisti chromanai ir naudojimo būdas
PL3167096T3 (pl) Dwuetapowy sposób nanoszenia
HUE046000T2 (hu) Antiproferatív vegyületek és alkalmazásuk módszerei
GB201514756D0 (en) Compound and method of use
IL251505A0 (en) Neuroactive compounds and methods of use thereof
LT3525583T (lt) Anti-c1s antikūnai ir jų naudojimo būdai
LT3271347T (lt) Priešgrybeliniai junginiai ir jų gamybos būdai
IL272851A (en) Methods of using dipivefrin
IL256322B (en) Improved formulations of deferasirox and methods of making the same
GB201609786D0 (en) Compounds and method of use
LT3562790T (lt) Pagrindų ir susijusių pagrindų atskyrimo būdas
PL3457851T3 (pl) Pochodne sobetiromu
IL313083A (en) Terlipressin compositions and their methods of use
BR112016025413A2 (pt) método de fabricação de um inserto e inserto
PL3630738T3 (pl) Sposób wytwarzania ozanimodu